Literature DB >> 34519823

Osteogenesis Imperfecta: The Impact of Genotype and Clinical Phenotype on Adiposity and Resting Energy Expenditure.

Kaitlin L Ballenger1, Nicol Tugarinov1, Sara K Talvacchio2, Marianne M Knue2, An N Dang Do2, Mark A Ahlman3, James C Reynolds3, Jack A Yanovski1, Joan C Marini4.   

Abstract

CONTEXT: Mutations in type I collagen or collagen-related proteins cause osteogenesis imperfecta (OI). Energy expenditure and body composition in OI could reflect reduced mobility or intrinsic defects in osteoblast differentiation increasing adipocyte development.
OBJECTIVE: This study compares adiposity and resting energy expenditure (REE) in OI and healthy controls (HC), for OI genotype- and Type-associated differences.
METHODS: We studied 90 participants, 30 with OI (11 COL1A1 Gly, 8 COL1A2 Gly, 4 COL1A1 non-Gly, 1 COL1A2 non-Gly, 6 non-COL; 8 Type III, 16 Type IV, 4 Type VI, 1 Type VII, 1 Type XIV) and 60 HC with sociodemographic characteristics/BMI/BMIz similar to the OI group. Participants underwent dual-energy x-ray absorptiometry to determine lean mass and fat mass percentage (FM%) and REE. FM% and REE were compared, adjusting for covariates, to examine the relationship of OI genotypes and phenotypic Types.
RESULTS: FM% did not differ significantly in all patients with OI vs HC (OI: 36.6% ± 1.9%; HC: 32.7% ± 1.2%; P = 0.088). FM% was, however, greater than HC for those with non-COL variants (P = 0.016). FM% did not differ from HC among OI Types (P values > 0.05).Overall, covariate-adjusted REE did not differ significantly between OI and HC (OI: 1376.5 ± 44.7 kcal/d; HC: 1377.0 ± 96 kcal/d; P = 0.345). However, those with non-COL variants (P = 0.016) and Type VI OI (P = 0.04) had significantly lower REE than HC.
CONCLUSION: Overall, patients with OI did not significantly differ in either extra-marrow adiposity or REE from BMI-similar HC. However, reduced REE among those with non-COL variants may contribute to greater adiposity. Published by Oxford University Press on behalf of the Endocrine Society 2021.

Entities:  

Keywords:  adiposity; osteogenesis imperfecta; resting energy expenditure

Mesh:

Substances:

Year:  2022        PMID: 34519823      PMCID: PMC8684495          DOI: 10.1210/clinem/dgab679

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass.

Authors:  D Gallagher; D Belmonte; P Deurenberg; Z Wang; N Krasnow; F X Pi-Sunyer; S B Heymsfield
Journal:  Am J Physiol       Date:  1998-08

Review 2.  Indirect calorimetry: technical aspects.

Authors:  L E Matarese
Journal:  J Am Diet Assoc       Date:  1997-10

Review 3.  Osteogenesis imperfecta: new genes reveal novel mechanisms in bone dysplasia.

Authors:  Heeseog Kang; Smriti Aryal A C; Joan C Marini
Journal:  Transl Res       Date:  2016-11-19       Impact factor: 7.012

4.  Physiological evidence of hypermetabolism in osteogenesis imperfecta.

Authors:  G J Cropp; D N Myers
Journal:  Pediatrics       Date:  1972-03       Impact factor: 7.124

5.  Skeletal muscle weakness in osteogenesis imperfecta mice.

Authors:  Bettina A Gentry; J Andries Ferreira; Amanda J McCambridge; Marybeth Brown; Charlotte L Phillips
Journal:  Matrix Biol       Date:  2010-07-06       Impact factor: 11.583

6.  Topological mapping of BRIL reveals a type II orientation and effects of osteogenesis imperfecta mutations on its cellular destination.

Authors:  Alexa Patoine; Marie-Hélène Gaumond; Prashant K Jaiswal; François Fassier; Frank Rauch; Pierre Moffatt
Journal:  J Bone Miner Res       Date:  2014-09       Impact factor: 6.741

7.  Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.

Authors:  Simón Méndez-Ferrer; Tatyana V Michurina; Francesca Ferraro; Amin R Mazloom; Ben D Macarthur; Sergio A Lira; David T Scadden; Avi Ma'ayan; Grigori N Enikolopov; Paul S Frenette
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta.

Authors:  S D Chipman; H O Sweet; D J McBride; M T Davisson; S C Marks; A R Shuldiner; R J Wenstrup; D W Rowe; J R Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Osteogenesis imperfecta: an expanding panorama of variants.

Authors:  D Sillence
Journal:  Clin Orthop Relat Res       Date:  1981-09       Impact factor: 4.176

Review 10.  Recessive osteogenesis imperfecta: clinical, radiological, and molecular findings.

Authors:  Marianne Rohrbach; Cecilia Giunta
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-07-12       Impact factor: 3.908

View more
  1 in total

1.  Osteogenesis Imperfecta: The Impact of Genotype and Clinical Phenotype on Adiposity and Resting Energy Expenditure.

Authors:  Kaitlin L Ballenger; Nicol Tugarinov; Sara K Talvacchio; Marianne M Knue; An N Dang Do; Mark A Ahlman; James C Reynolds; Jack A Yanovski; Joan C Marini
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 5.958

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.